North America Adhesion Barrier Market

North America Adhesion Barrier Market Size & Growth (2023 to 2028):

As per the research report, the size of the North America Adhesion Barrier Market was valued at USD 424.34 million in 2023 and estimated to be growing at a CAGR of 8.15%, to reach USD 627.84 million by 2028.

DRIVERS

According to the National Cancer Institute, in 2019, approximately 1.75 million new cases of cancer were diagnosed in the United States. The increase in the geriatric population also significantly increases the use of adhesion barriers, as they suffer from various chronic diseases, increased incidence of gynecological disorders, neurological disorders, etc. heart disorders and ophthalmic disorders requiring surgery.

According to the World Health Organization (WHO), one in four people living in North America and Europe could be 65 or older by 2045. The number of people over age group 80 is expected to reach 428 million by 2050. In addition, with increasing urbanization and increasing inclination towards a healthy lifestyle, more people are expected to engage in various sporting activities. Hence, the result is an increase in sports-related injuries, which increases the use of anti-adhesion barriers. These factors play a key driving role in growth rate.

RESTRAINTS

On the other hand, due to the growing threat of adherence, after surgical treatment, the market still today sees barriers in terms of usability, a lack of awareness on the importance of the treatment as well as the need for health requirements, restraint market growth.

OPPORTUNITIES

The Covid-19 epidemic has posed a number of challenges for the health sector, weighing it down with a rapid number of cases. This has resulted in a reduction in the number of surgeries and, in turn, a weakening of the demand for adhesion barriers.

However, by mid-2022 the number of surgeries increased, leading to the sale of a variety of new opportunities for surgical tools and devices, such as adhesion barriers. This will cause better growth prospects for the adhesion barrier market in the region than in pre-pandemic business scenario.

CHALLENGES

Strict regulatory approvals and brand loyalty makes it difficult for new products to garner market sales, which can challenge the growth rate of the market.

This research report on the North America Adhesion Barrier Market has been segmented and sub-segmented into the following categories:

By Product:

• Synthetic
• Natural

By Product Form:

• Film
• Gel
• Liquid                                                                                                           

By Surgical Application:

• Gynecological
• Cardiovascular
• Neurological
• Orthopaedic
• General/Abdominal
• Urological
• Reconstructive

By Country:

• U.S
• Canada
• Rest of North America

REGIONAL ANALYSIS

The Americas are currently at the forefront of the global market and are expected to maintain their leadership position throughout the analysis period, given the strong presence of a massive group of medical device suppliers. The growing number of comprehensive research and development activities and the increase in laparoscopic procedures will also drive the demand for adhesion barriers in the years to come.

The increasing rate of surgeries in the region is well noted. Growth in the United States is driven by advancements in technology, older patients who expect higher levels of function, and reimbursement models that encourage complex fusion surgery.

Adhesion barriers are also useful in cancer surgeries. According to the American Cancer Society estimate, new cases of lung cancer in the United States for 2019 are expected to be around 2.35 million, and around 154,150 deaths are expected from lung cancer. The National Institutes of Health estimated that cancer treatment cost the United States a total of $ 150.5 billion in 2018, of which $ 14.4 billion was due to lung cancer. Surgeons believe they can cost-effectively reduce the risk of postoperative complications in patients through the use of adhesion barriers. Hence, these new advancements are expected to drive the market growth in North America.

Companies playing a dominant role in the North America Adhesion Barrier Market profiled in this report are Baxter International Inc., Medtronic Plc., C. R. Bard, Inc., Johnson & Johnson, Sanofi Group, Atrium Medical Corporation, Integra Lifesciences Corporation, Anika Therapeutics Inc., FzioMed, Inc., and MAST Biosurgery AG.